JNJ SEC Filings
SEC filings for JNJ. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 10-KAIThe MD&A is predominantly factual and backward-looking, reporting solid 6% sales growth, strong oncology and cardiovascular performance, and a large talc reserve reversal that lifted pre-tax margin. | Feb 11, 2026 | 0000200406-26-000016EDGAR |
SEC filings for companies related to JNJ
Never miss a JNJ filing.
Get an email when JNJ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.